Free tool
Upcoming earnings calendar
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the next 30, 60 or 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
See who reports in the UK in the next 90 days, from the ~22,000 stocks we cover — filter by cap, sector, theme or market, then open any ticker for the full analysis.
5 companies reporting in the next 90 days. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Theme | Market cap (USD) | 1M return | |
|---|---|---|---|---|---|
| Tuesday, Oct 27 · in 61 days · 1 company | |||||
| KNSA | Kiniksa Pharmaceuticals International, plc | Rare disease | $6.05B | −0.96% | |
| Thursday, Nov 5 · in 70 days · 1 company | |||||
| SLN | Silence Therapeutics plc | Rare disease | $840.94M | +17.14% | |
| Monday, Nov 9 · in 74 days · 3 companies | |||||
| ROIV | Roivant Sciences Ltd. | Rare disease | $26.55B | +8.60% | |
| MREO | Mereo BioPharma Group plc | Rare disease | |||
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock. Looking for a name that isn't listed? Jump straight to it:
| $44.39M |
| −10.03% |
| 0A9G.L | Mereo BioPharma Group plc | Rare disease | — | −2.36% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India). Reporting dates are public estimates and can shift.